James Parslow
2021
In 2021, James Parslow earned a total compensation of $520.8K as Chief Financial Officer at Xenetic Biosciences, a 45% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $68,079 |
|---|---|
| Option Awards | $117,026 |
| Salary | $299,250 |
| Other | $36,454 |
| Total | $520,809 |
Parslow received $299.3K in salary, accounting for 57% of the total pay in 2021.
Parslow also received $68.1K in non-equity incentive plan, $117K in option awards and $36.5K in other compensation.
Rankings
In 2021, James Parslow's compensation ranked 10,642nd out of 12,405 executives tracked by ExecPay. In other words, Parslow earned more than 14.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,642 out of 12,405 | 14th |
Division Manufacturing | 4,699 out of 5,494 | 15th |
Major group Chemicals And Allied Products | 2,111 out of 2,369 | 11th |
Industry group Drugs | 1,875 out of 2,090 | 10th |
Industry Pharmaceutical Preparations | 1,385 out of 1,537 | 10th |
Source: SEC filing on October 17, 2022.
Parslow's colleagues
We found two more compensation records of executives who worked with James Parslow at Xenetic Biosciences in 2021.